Can artificial intelligence simplify the screening of muscle mass loss?

Background: Sarcopenia is a risk factor for morbidity and preventable mortality in old age, with consequent high costs for the national health system. Its diagnosis requires costly radiological examinations, such as the DEXA, which complicate screening in medical centers with a high prevalence of sa...

Full description

Bibliographic Details
Main Authors: Enrico Buccheri, Daniele Dell’Aquila, Marco Russo, Rita Chiaramonte, Giuseppe Musumeci, Michele Vecchio
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023035302
_version_ 1827937288506572800
author Enrico Buccheri
Daniele Dell’Aquila
Marco Russo
Rita Chiaramonte
Giuseppe Musumeci
Michele Vecchio
author_facet Enrico Buccheri
Daniele Dell’Aquila
Marco Russo
Rita Chiaramonte
Giuseppe Musumeci
Michele Vecchio
author_sort Enrico Buccheri
collection DOAJ
description Background: Sarcopenia is a risk factor for morbidity and preventable mortality in old age, with consequent high costs for the national health system. Its diagnosis requires costly radiological examinations, such as the DEXA, which complicate screening in medical centers with a high prevalence of sarcopenia. Objectives: Developing a nearly zero-cost screening tool to emulate the performance of DEXA in identifying patients with muscle mass loss. This can crucially help the early diagnosis of sarcopenia at large-scale, contributing to reduce its prevalence and related complications with timely treatments. Methods: We exploit cross-sectional data for about 14,500 patients and 38 non-laboratory variables from successive NHANES over 7 years (1999–2006). Data are analyzed through a state-of-the-art artificial intelligence approach based on decision trees. Results: A reduced number of anthropometric parameters allows to predict the outcome of DEXA with AUC between 0.92 and 0.94. The most complex model derived in this paper exploits 6 variables, related to the circumference of key corporal segments and to the evaluation of body fat. It achieves an optimal trade-off sensitivity of 0.89 and a specificity of 0.82. Restricting exclusively to variables related to lower limb, we obtain an even simpler tool with only slightly lower accuracy (AUC 0.88–0.90). Conclusions: Anthropometric data seem to contain the entire informative content of a more complex set of non-laboratory variables, including anamnestic and/or morbidity factors. Compared to previously published screening tools for muscle mass loss, the newly developed models are less complex and achieve a better accuracy. The new results might suggest a possible inversion of the standard diagnostic algorithm of sarcopenia. We conjecture a new diagnostic scheme, which requires a dedicated clinical validation that goes beyond the scope of the present study.
first_indexed 2024-03-13T08:23:22Z
format Article
id doaj.art-0b51656095d64a46adbfe7b5858100c3
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T08:23:22Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-0b51656095d64a46adbfe7b5858100c32023-05-31T04:47:12ZengElsevierHeliyon2405-84402023-05-0195e16323Can artificial intelligence simplify the screening of muscle mass loss?Enrico Buccheri0Daniele Dell’Aquila1Marco Russo2Rita Chiaramonte3Giuseppe Musumeci4Michele Vecchio5Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy; Corresponding author. Via Santa Sofia 89, Torre Biologica, University of Catania, 95123, Catania, Italy.Dipartimento di Fisica “Ettore Pancini”, University of Naples “Federico II”, Napoli, Italy; INFN – Sezione di Napoli, Napoli, Italy; Corresponding author. Via Cinthia 21, Complesso Universitario di Monte S. Angelo, Dipartimento di Fisica “Ettore Pancini”, University of Naples “Federico II”, 80126, Napoli, Italy.Department of Physics and Astronomy, University of Catania, Catania, Italy; INFN – Sezione di Catania, Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Human, Histology and Movement Science Section, University of Catania, 95123, Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy; Rehabilitation Unit, “AOU Policlinico G. Rodolico-San Marco”, 95123 Catania, ItalyBackground: Sarcopenia is a risk factor for morbidity and preventable mortality in old age, with consequent high costs for the national health system. Its diagnosis requires costly radiological examinations, such as the DEXA, which complicate screening in medical centers with a high prevalence of sarcopenia. Objectives: Developing a nearly zero-cost screening tool to emulate the performance of DEXA in identifying patients with muscle mass loss. This can crucially help the early diagnosis of sarcopenia at large-scale, contributing to reduce its prevalence and related complications with timely treatments. Methods: We exploit cross-sectional data for about 14,500 patients and 38 non-laboratory variables from successive NHANES over 7 years (1999–2006). Data are analyzed through a state-of-the-art artificial intelligence approach based on decision trees. Results: A reduced number of anthropometric parameters allows to predict the outcome of DEXA with AUC between 0.92 and 0.94. The most complex model derived in this paper exploits 6 variables, related to the circumference of key corporal segments and to the evaluation of body fat. It achieves an optimal trade-off sensitivity of 0.89 and a specificity of 0.82. Restricting exclusively to variables related to lower limb, we obtain an even simpler tool with only slightly lower accuracy (AUC 0.88–0.90). Conclusions: Anthropometric data seem to contain the entire informative content of a more complex set of non-laboratory variables, including anamnestic and/or morbidity factors. Compared to previously published screening tools for muscle mass loss, the newly developed models are less complex and achieve a better accuracy. The new results might suggest a possible inversion of the standard diagnostic algorithm of sarcopenia. We conjecture a new diagnostic scheme, which requires a dedicated clinical validation that goes beyond the scope of the present study.http://www.sciencedirect.com/science/article/pii/S2405844023035302Muscle mass lossSarcopeniaArtificial intelligenceBoost decision trees
spellingShingle Enrico Buccheri
Daniele Dell’Aquila
Marco Russo
Rita Chiaramonte
Giuseppe Musumeci
Michele Vecchio
Can artificial intelligence simplify the screening of muscle mass loss?
Heliyon
Muscle mass loss
Sarcopenia
Artificial intelligence
Boost decision trees
title Can artificial intelligence simplify the screening of muscle mass loss?
title_full Can artificial intelligence simplify the screening of muscle mass loss?
title_fullStr Can artificial intelligence simplify the screening of muscle mass loss?
title_full_unstemmed Can artificial intelligence simplify the screening of muscle mass loss?
title_short Can artificial intelligence simplify the screening of muscle mass loss?
title_sort can artificial intelligence simplify the screening of muscle mass loss
topic Muscle mass loss
Sarcopenia
Artificial intelligence
Boost decision trees
url http://www.sciencedirect.com/science/article/pii/S2405844023035302
work_keys_str_mv AT enricobuccheri canartificialintelligencesimplifythescreeningofmusclemassloss
AT danieledellaquila canartificialintelligencesimplifythescreeningofmusclemassloss
AT marcorusso canartificialintelligencesimplifythescreeningofmusclemassloss
AT ritachiaramonte canartificialintelligencesimplifythescreeningofmusclemassloss
AT giuseppemusumeci canartificialintelligencesimplifythescreeningofmusclemassloss
AT michelevecchio canartificialintelligencesimplifythescreeningofmusclemassloss